Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

<p>Trial schema</p>

Saved in:
Bibliographic Details
Main Author: Stephanie L. Wethington (16354020) (author)
Other Authors: Payal D. Shah (14942077) (author), Lainie Martin (16354023) (author), Janos L. Tanyi (15047976) (author), Nawar Latif (16354026) (author), Mark Morgan (16354029) (author), Drew A. Torigian (15047964) (author), Diego Rodriguez (16354032) (author), Simon A. Smith (16354035) (author), Emma Dean (16354038) (author), Susan M. Domchek (14944434) (author), Ronny Drapkin (14937867) (author), Ie-Ming Shih (14964062) (author), Eric J. Brown (16354041) (author), Wei-Ting Hwang (15045089) (author), Deborah K. Armstrong (15134754) (author), Stephanie Gaillard (14947156) (author), Robert Giuntoli (16354044) (author), Fiona Simpkins (15048000) (author)
Published: 2025
Subjects:
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Clinical Trial Results
Drug Resistance
Gynecological Cancers
Ovarian cancer
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items